Iantrek
PrivateLast Round
Debt
Apr 28, 2026
Est. Valuation
$95M
Total Funding Raised
$100.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Iantrek is an ophthalmic medical technology company that develops micro- and bio-interventional solutions for the surgical treatment of chronic eye diseases, with a primary focus on glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iantrek Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Iantrek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 28, 2026 | ||||
| Series C | Aug 20, 2025 | ||||
| Series B | Aug 30, 2022 | ||||
| Series A Extension | Oct 22, 2020 |
Key People
Founding team and executive leadership
Iantrek Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Venture Partners | Series C |
| aMoon | Series C |
| Trinity Capital | Debt |
| Sectoral | Series C, Series B |
| Visionary Ventures | Series C, Series B |
| Civilization Ventures | Series C |
| JSD Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
$30M round led by Trinity Capital.
- Mar 31, 2026
Introducing AlloSpan Canal, a bio-reinforced platform for ophthalmic surgery.
Iantrek Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iantrek's valuation, stock price, and market status.